| Overall survival | |||
---|---|---|---|---|
Univariate | Multivariate | |||
HR (95% CI) | P | HR (95% CI) | P | |
Stagea | ||||
0 + IA + IB IIA IIB III + IV | 1.0 (reference) 1.159 (0.714–1.881) 1.356 (0.854–2.151) 3.035 (1.301–7.081) | 0.549 0.196 0.010 | 1.0 (reference) 5.705 (1.929–16.88) 6.270 (2.160–18.20) 11.10 (3.012–40.92) | 1.650e–03 7.361e–04 2.985e–04 |
Age | 1.025 (0.998–1.053) | 0.067 | 1.024 (0.996–1.052) | 0.086 |
Gender | 1.249 (0.771–2.023) | 0.366 | 1.236 (0.759–2.012) | 0.393 |
CCDC88A expression | 0.497 (0.295–0.836) | 0.008 | 0.519 (0.306–0.877) | 0.014 |
Diameter of primary tumor | 1.338 (1.176–1.524) | 1.045e–05 |  |  |
Histologyb | 1.383 (0.846–2.261) | 0.1965 |  |  |
Lymphatic invasionb (ly0 + ly1 or ly2 + ly3) | 1.269 (0.751–2.145) | 0.3733 |  |  |
Venous invasionb (v0 + v1 or v2 + v3) | 1.928 (1.034–3.593) | 0.0388 |  |  |
Intrapancreatic nerve invasionb (n0 + n1 or n2 + n3) | 1.500 (0.947–2.377) | 0.0839 |  |  |